Longitudinal Impact of the Smoking Ban Legislation in Acute Coronary Syndrome Admissions by Abreu, D. et al.
Research Article
Longitudinal Impact of the Smoking Ban Legislation in
Acute Coronary Syndrome Admissions
D. Abreu,1 P. Sousa,1,2 C. Matias-Dias,1,2,3 and F. J. Pinto4
1Escola Nacional de Sau´de Pu´blica, Universidade Nova de Lisboa, Avenida Padre Cruz, 1600-560 Lisboa, Portugal
2Centro de Investigac¸a˜o em Sau´de Pu´blica, ENSP-UNL, Avenida Padre Cruz, 1600-560 Lisboa, Portugal
3Department of Epidemiology, The Instituto Nacional de Sau´de Doutor Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisboa, Portugal
4Servic¸o de Cardiologia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, EPE, Centro Acade´mico Medicina de Lisboa and
Centro Cardiovascular da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisboa, Portugal
Correspondence should be addressed to D. Abreu; da.abreu@ensp.unl.pt
Received 25 August 2016; Revised 22 December 2016; Accepted 17 January 2017; Published 7 February 2017
Academic Editor: Nikolaos Siafakas
Copyright © 2017 D. Abreu et al.This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background and Purpose. The association between smoking and CV has been proved; however smoking is still the first preventable
cause of death in the EU.We aim to evaluate the potential impact of the smoke ban on the number of ACS events in the Portuguese
population. In addition, we evaluate the longitudinal effects of the smoking ban several years after its implementation. Methods.
We analyzed the admission rate for ACS before and after the ban using data from hospital admission. Monthly crude rate was
computed, using the Portuguese population as the denominator. Data concerning the proportion of smokers among ACS patients
were obtained from the NRACS. Interrupted time series were used to assess changes over time. Results. A decline of −5.8% was
found for ACS crude rate after the smoking ban.The decreasing trend was observed even after years since the law.The effect of the
ban was higher in men and for people over 65 years. The most significant reduction of ACS rate was found in Lisbon. Conclusions.
Our results suggest that smoking ban is related to a decline in ACS admissions, supporting the importance of smoke legislation as
a public health measure, contributing to the reduction of ACS rate.
1. Introduction
Tobacco is now considered one of the most important public
health issues and a major determinant of preventable mortal-
ity and morbidity in developed and developing countries [1,
2]. Diseases associatedwith tobacco consumption encompass
a significant burden on individuals, societies, and healthcare
systems.
Smoking affects not only active smokers but also those
who are exposed to secondhand smoke in the vicinity of
a smoker [3]. Passive smoking has been associated with
an increase in relative risk of coronary heart disease; in
some studies the exposure of nonsmokers to secondhand
smoke was associated with a 25% increased risk of coronary
artery disease andmyocardial infarction [4]. Even short-term
passive smoking appears to cause damage in the endothelial
function that could immediately compromise the cardiovas-
cular system [5].
By 2013 smoking, including secondhand smoking, was
responsible for the death of approximately 12 350 people
(around 11%) in Portugal [6].
The association between smoking and cardiovascular dis-
ease (CVD) has been extensively proved; however smoking
is still the first preventable cause of death in the European
Union [7]. Several meta-analysis showed a reduction on
coronary events after the implementation of smoke-free
legislation; this suggests potential to achieve vast public
health benefits [8]. However fewer studies have demonstrated
if the reduction effect lasted after the immediate period of the
law implementation [8]. Furthermore smoking bans benefit
nonsmokers and smokers. Nonsmokers benefit from the ban
as they are exposed to significantly less secondhand smoke,
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while smokers tend to smoke less, have greater cessation
success, and experience increased confidence in their ability
to quit [9].
Portugal was one of the countries that signed the WHO
Framework Convention on Tobacco Control [10], leading to
the implementation of the most recent antismoking mea-
sure, the 37/2007 legislation implemented in January 2008
[11]. This legislation contained new framework to protect
individuals from passive smoking and to encourage cutting
down/stopping tobacco consumption to ensure protection
against secondhand smoke [11, 12]. This law banned smoking
in all enclosed public places, such as hospitals, public trans-
portations, andworkplaces. Besides this, it established further
regulation for the information provided on tobacco products,
packaging, and labeling, as well as further restrictions on the
advertising [13].
Within the context of the growing body of consistent
evidence that supports the assumption of the smoking ban
being the leading cause for the decrease in the number of
Acute Coronary Syndrome (ACS) events, we aim to evaluate
the potential impact of the smoke legislation on the number
of ACS events in the Portuguese population. In addition we
aim to analyze the longitudinal effects of the smoking ban
several years after its implementation and investigate trends
by age, sex, and region.
2. Methods
2.1. Data. Data was obtained from the Diagnosis Related
Group (DRG) National Database that collects data from
all admissions into Portuguese public hospitals (mainland
Portugal), holding data on primary diagnosis and some
demographic variables such as sex and age, as well as the
geographic region of the admission [14].
All admission cases from 2002 to 2014 were extracted
and only participants with ages over 20 years old and with
primary diagnosis of ACS coded in ICD 9 (international
classification of disease, 9th revision) as 410.00-410.xx to
identify admissions diagnosis of AcuteMyocardial Infarction
(AMI) and 4130 codes, to identify unstable angina, were
analyzed.
Data from the National Registry of Acute Coronary
Syndrome (NRACS) that gathers information on the diag-
nosis and treatment of ACS, being considered a surpassing
source of information in Portugal [15], was used from the
period of 2002 to 2010, in order to obtain the proportion
of ACS patients that were current smokers. This dataset
has the advantage of being integrated into the Euro Heart
Survey platform and, consequently uses the CardiologyAudit
and Registration Data Standards (CARDS) system. This
system ensures that credible and comparable information is
collected in several European countries over time as they use
standardized information, in terms of both the definition and
the coding of variables and in the form of measurement and
collection of data. As data being validated and standardized
allows for the possibility of applying and validating analysis
in other larger populations, thus we are able to obtain more
robust results [16].
Smoking legislation was implemented in January 2008,
providing six years of data before the implementation of
the legislation (January 2002 through December 2007) and
seven years of data after the implementation of the legislation
(January 2008 through December 2014).
The unit of analysis was monthly admission for ACS
rather than an individual patient, so it was possible for a
person to be counted more than once, since changes in the
number of admissions were also expected to be affected by
the legislation.
All data analyzed were deidentified.
2.2. Statistical Analysis. In order to estimate ACS crude event
rates population estimates by age and sex were obtained from
the National Institute of Statistics for each year and were used
as denominators.
ACS crude event rates (per 100000 adults) were com-
puted for each month, using the population of the country,
restricted to adult population resident in mainland Portugal
with ages over 20 years. Crude rates were calculated as the
number of ACS events divided by the population.
To evaluate changes over time, we used an interrupted
time series design, implementing a segmentedmultiple linear
regression model. These models are useful when the rela-
tionship between the response and the independent variables
is piecewise linear, namely, represented by two or more
straight lines connected at unknown values, which are usually
referred as breakpoints [17]. In this study, the segmented
model was implemented in order to test whether there was
a significant change in the number of ACS events after the
introduction of smoke-free legislation.
The response variable was the monthly crude event rate
of ACS. The impact of smoke-free legislation, defined as a
change in the rate of admissions for ACS after the legislation,
was assessed by including January 2008 as breakpoint in
the regression. Difference between slopes, before and after
the legislation, was assessed through Davies test. A month
indicator variable was introduced to adjust for seasonality in
ACS admissions.
All analyses were stratified by sex, age, and region. Age
was grouped into two categories <65 and ≥65 years old.
We further stratify data per NUTSII regions for mainland
Portugal (Alentejo region, Algarve region, Midlands region,
Lisbon and Tagus Valley region, and North region) in order
to check for any marked reduction in regions with big cities,
such as Lisbon and some cities in the North region.
Autocorrelation between month estimates was incorpo-
rated adequately into the model, with the presence of short-
term autocorrelation applying a first-order autoregressive,
AR (1), structure to the residuals.
Using data from the NRACS, we computed the monthly
proportion of patients with ACS diagnosis that were current
smokers for the period of 2002 to 2010. The proportion was
obtained by dividing the number of monthly smokers by the
total smokers included in the database for the study period.
In order to assess if there was a significant decrease in the
proportion of smokers after 2008 another segmentedmultiple
linear regressionmodel was implemented andDavies test was
used to assess for significant changes in slopes.
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Figure 1: Longitudinal trends for overall monthly crude rates (per
100000 adult population) of ACS admissions from January 2002 to
December 2014. Prelegislation and postlegislation periods.
Models were fitted in R version 2.3.2 software using the
library segmented [18].
3. Results and Discussion
3.1. Results. A total of 190,974 cases of ACS were registered in
the country (mainland Portugal), from 2002 to 2014, of which
64% were males.
We assessed crude rates (per 100000 adults) of monthly
admission by ACS for the period of 2002 and 2014. Our
results show a decline of ACS events by 2008, year of the
law implementation, that was used as a breakpoint in the
model created (Figure 1). A positive trend was observed
for the years preceding the smoking ban (yearly trend of
0.004 events per 100000; 3.8%). For the period after the
legislation took place, the trend observed for ACS crude rate
was negative, with a decrease of 0.0018 events per 100000, that
is, a decline of −1.7% by year after the legislation (Table 1).
The difference between the two slopes for the trends before
and after the legislation was significant (−0.006 events per
100000, 𝑝 < 0.001) in the overall population (Table 1) with
a decline of ACS events of −5.8%. We stratified the ACS
events by sex, and the trends observed for the prelegislation
and postlegislation periods were similar for both men and
women (Table 1). Although the trends were similar, the
reduction in ACS event crude rate was more marked in men
(−0.0046 events per 100000; −4.8%, 𝑝 value = 0.0002) than
women (−0.0033 events per 100000;-3.2% 𝑝 value = 0.0002).
However, the results obtained formales should be interpreted
with caution as the confidence interval for the slope after the
implementation of the law is wider than the one obtained for
women and zero was included.
The results for age stratification show a significant reduc-
tion in ACS rate after the legislation took place for people
over 65 years old (−0.014 events per 100000; −13% 𝑝 value <
0.001); however this finding was not verified for people under
65 years old.
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Figure 2: Proportion of ACS patients that are current smokers.
Results stratified by region show that the only region with
a significant decrease in ACS events after the implementation
of the law was Lisbon and Tagus Valley (change in slope of
−0.013 events per 100000, 12.4%, 𝑝 value < 0.001). Although
the North region also showed a trend in decrease after the
implementation of the law this reduction was not significant
(change in slope of −0.003 per 100000, −2.9%, 𝑝 value =
0.168). The remaining regions did not show any significant
change.
The seasonal pattern observed was consistent with that
reported elsewhere [19], with higher rates of admission over
the winter and lower rates during the summer.
The analysis of the NRACS data allowed us to assess
the proportion of ACS patients that were currently smokers
for the period 2002 to 2010. At the time of the registry, the
proportion of smokers among ACS patients has been steadily
declining over the years; however the decrease observed after
2008 was not significant (𝑝 value = 0.997) (Figure 2).
4. Discussion
The mechanism by which tobacco smoke is associated with
ACS has been highly studied, proving that small exposures
seem to increase platelet aggregation and alter endothe-
lial function causing other hemodynamic changes that can
increase or trigger ACS events [20].
The magnitude of the effect of smoke regulations on ACS
events has been found to be very broad, from studies that
found no significant reduction after the smoking ban [21, 22]
to studies that found very large effects from 27% to 40%
reductions [23, 24]. However, these two last studies had very
small sample sizes and had a very limited time after the ban
(6 months).
The pooled estimate, obtained from a meta-analysis that
included more than 30 studies, showed a risk reduction of
10% in ACS events after the smoking ban (95% CI 6 to 14,
𝑝 < 0.001) [8]. Anothermeta-analysis study showed a pooled
reduction up to 15% in ACS events after the implementation
of the law [25].
Our results show that the implementation of a law to
regulate smoking was associated with a decline of hospital
admissions by ACS. The change in trend of ACS events
from the period before the legislation to the period after the
legislation was a decrease of 5.8%. Moreover the trend of
ACS events for the period before the smoke legislation was
increasing.
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Table 1: Results of multiple linear regression analyses to detect association between smoke-free legislation and monthly crude rates of ACS
admissions per 100000.
Prelegislation trend (change
per month)
Change in trend in postlegislation period
compared to prelegislation
Postlegislation trend (change
per month)
Overall
𝛽∗ 0.004 −0.006 −0.0018
IC for 𝛽 0.0029; 0.0055 𝑝 value < 0.001 −0.0033; −0.0004
Yearly change% 3.84 5.76 1.73
Males
Β∗ 0.0034 −0.0046 −0.0012
IC for 𝛽∗ 0.0021; 0.0047 𝑝 value = 0.0002 −0.0028; 0.0004
Yearly change% 3.26 4.80 1.15
Females
Β∗ 0.0017 −0.0033 −0.0016
IC for 𝛽 0.0008; 0.0023 𝑝 value = 0.0002 −0.0027; −0.0004
Yearly change% 1.63 −3.17 −1.54
Age ≥ 65
Β∗ 0.0016 −0.01352 −0.0119
IC for 𝛽 −0.0018; 0.0051 𝑝 value < 0.001 −0.01625; −0.0075
Yearly change% 1.54 −12.98 −11.42
Age < 65
Β∗ 0.0011 −0.0052 −0.0483
IC for 𝛽 0.0008; 0.0014 𝑝 value = 0.2692 −0.1573; 0.0607
Yearly change% 1.06 −4.99 −4.64
∗All regression models were adjusted for seasonal effects.
Although the effect of the reduction is not as high as
some other studies, this could be explained by the fact that
Portugal is among the countries with the lowest proportion of
smokers in Europe (around 23%) [6, 26]. However according
to the report from the Directorate-General of Health and the
National Health Institute, constituting a partnership called
InfoTabac, the proportion of smokers decreased by 1% in
2009, compared to 2006, but between 2009 and 2012 the
smoking rate has remained stable in Portugal [10, 27], as
well as for the period between 1995 and 2006 by which the
prevalence of smokers was also stable [28].
On the other hand inconsistent compliance with the
smoking law has been reported in few studies. The irregu-
larities in the compliance with the law may be due to some
ambiguities/gaps in the law, lack of practical definitions, and
absence or delay in the effective application of penalties in
case of law violations [29, 30].
A study published using Portuguese data on asthma [12]
demonstrated that at least 39.6% of the sample described
positive changes such as improvement of daily life activities
performance, decrease in symptoms or lesser recourse to SOS
medication, after the implementation of the law. From this
group, 81.6% reported that since the implementation of the
law, they were no longer exposed to secondhand smoke. This
reinforces the hypothesis of an association between smoking
ban regulation and positive health outcomes.
The seasonal pattern observed in Figure 1 was consistent
with that reported in other studies [31, 32], higher rates of
admission during the winter (especially around December
and January) and lower rates in the summer.The higher rates
of ACS during the winter could be explained by increases in
blood pressure and in fibrinogen on cold days as well as the
increase in infectious diseases, which are more common in
industrialized countries during colder weather [33].
In January 2009, the year after the implementation of the
law, a cold wave was experienced in Portugal explaining the
spike in ACS rates presented in Figure 1 [34].
Bearing in mind that most of the meta-analyses studies
[8, 35, 36] evidenced that longer follow-up times were needed
to assess later effects of the legislation, as, in fact, the longer
smoke-free policies are in place, the more pronounced are
their effects on smoking behavior [37]. Thus the reduction in
ACS rates observed over time in our study suggests that the
effect of the legislation was sustained over time. One possible
explanation for later effects is they are due to less rapidly
mediated effects on atherosclerosis severity and prevalence
[38].
Due to the longer duration of our study, compared to
most studies, and the fact that hospital admissions were cap-
tured through a large andwell-validated population database,
a better delineation of trends was allowed [8, 35].
Our results show thatmales were associatedwith a greater
reduction of ACS events after the legislation in declination
of women. Several studies confirm these results showing
more effects in male population than in female population
[31, 39–42]. According to the Directorate-General of Health
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there is a higher rate of ACS events among men than among
women; this could potentially increase power to detect an
effect in men [38, 41, 43]. The fact that women present lower
prevalence of tobacco consumption thanmen [44] could lead
to lower the impact of the law, although this would not affect
secondhand smoking.
The results stratified by age show a significant reduction
of ACS events for older people, age over 65 years old; however
no significant effect was found for people under 65 years old.
The fact that older people are more vulnerable to exposure
to secondhand smoking may trigger ACS events. Also it is
known that arterial wall stiffness increases in subjects over 55
years. Studies performed in Mediterranean populations such
as Spain and Italy showed similar effects in older subjects [42,
43, 45].
Although one of the main purposes of smoking bans
is to decrease exposure to secondhand smoke, we assessed
the proportion of ACS patients that reported to be current
smokers using the NRACS data (Figure 2). Although the pro-
portion of smokers with ACS diagnosis decreased from 2002
there is not a marked decrease after 2008. The proportion
of smokers remained very stable between 2006 and 2010;
this is consistent with the other studies. Barone-Adesi and
colleagues calculated that the contribution of reduced active
smoking to the reduction found in ACSwas less than 1% [22].
In addition the study from Ferrante and colleagues reported
that the implementation of the law did not impact smoking
prevalence [46].
The findings for each region show a significant decrease
only for Lisbon and Tagus Valley region. As Lisbon is the
capital of country one could argue that people on bigger
cities are more likely to frequent cafes, restaurants, and bars,
benefiting most people from any reduction in secondhand
smoking, even at low levels [21]. The North region of the
country also includes big cities, so although it was not
significant there was a decreasing trend in ACS events.
Although the Alentejo region is the region with higher
rate in male regular smokers in mainland Portugal [26]
the fact that no reduction in ACS rate was found after
the implementation of the law could be related to the fact
that changes in smoking behaviors may be more difficult in
regions with more rural areas [47].
There are encouraging indications suggesting the effects
of smoking law regulation in reducing the number of ACS
events in the Portuguese population. However we recognize
some limitations of the study. Like any ecological study, it
is not possible to prove directly the association between
the implementation of smoking law and the decline in the
number of ACS events. On the other hand, by 2010 a law
aiming to reduce salt in bread and making it mandatory
to include information on salt content in packed food was
implemented in Portugal. Although the effect of this law
may be related to the declining in ACS events after 2010,
the reduction in ACS rate was significant by the beginning
of 2008, year of the implementation of law. Furthermore,
more studies are needed to assess the effect of salt reduction
legislation on ACS events.
Moreover, our study has some strengths as the availability
of information on gender, age, and region which allowed
us to assess the robustness of our findings among different
subgroups. Also the time series method is preferred over the
simpler pre- and postproportion comparison method that
does not take the preintervention trend into account and also
allows correction for autocorrelation [48]. The fact that we
used two well validated and standardized databases is also
a major strength as this allows for an easy comparison with
other international studies mainly those developed in other
European countries.
5. Conclusions
Our study extended the existing literature on public health
interventions and suggests that smoking legislation is related
to a decline in ACS admissions supporting the importance
of smoke legislation for public health. Considering that
coronary heart disease is one of the leading causes of death in
Portugal, even a small reduction in the number of ACS events
has important health and economic gains.
The increasing number of ACS events verified from 2002
to 2008, before the implementation of the law, may suggest
that the decline of 5.8% in ACS events shown in our study
is associated with the introduction of smoking legislation. It
also suggests that the decline in the number of ACS events is
not related to long term trends.
Our results provide encouragement for legislators and
public health authorities to keep the efforts to ensure law
compliance and to create new normative instruments and
clinical and policy strategies to reduce the burden of ACS.
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